|
Objective:Observation of xiaoke capsule on diabetic nephropathy of kidney of liver and kidney Yin deficiency and blood stasis in patients with clinical efficacy, evaluating the effectiveness of its role.Method:Eligible to collect clinical diagnosed as diabetic nephropathy in 60 cases of patients with outpatient and inpatient, take a randomized test methods, divided into treatment 30 cases, control group of 30 cases of, all patients in the treatment on the basis of General, blood glucose, blood pressure control in the required level. Two groups of patients are given enalapril maleate tablets, pancreatic kallikrein enteric-coated tablets, the treatment group in the control group and on the basis of diabetes renal capsule, course of treatment for 60 days. Observation on changes of symptoms and signs in two groups, and fasting test respectively before and after treatment in patients with venous plasma glucose, postprandial 2H venous blood sugar, glycosylated hemoglobin, 24-hour urine protein quantitative, serum creatinine and urea nitrogen.Results:Treatment for 60 days after treatment group total effective rate 86.7%; control group total effective rate 63.3%.Through statistical analysis, significant difference (P<0.05).Conclusions:Renal capsule reduces diabetes urine protein, can make in patients with diabetic nephropathy decline in serum creatinine, urea nitrogen, can significantly reduce clinical symptoms, reduce the role of blood glucose and glycated hemoglobin is not obvious, can improve the efficacy, speculated that its mechanism may regulate metabolism, reduce renal Hyperfiltration in DN, reducing urine protein excretion, improve renal microcirculation, delay the progress of DN-related.
|